The purpose of this study is to test the safety of a drug called CA-4948 in combination with gemcitabine and nab-paclitaxel. Gemcitabine and nab-paclitaxel have already been approved by the FDA to be given through a vein in your arm. This study tests different doses of the drug CA-4948 to see which dose is safer for people. There will be about 36 people taking part in this study.
COM_RESEARCHSTUDIES_DETAIL_HEADER_BASIC_CONTACT_4
United States (Nationwide)
Ashwin Somasundaram
LCCC - Clinical Trials
Clinical or Medical
Interventional
Cancer (Pancreatic)
23-1040
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
